FRONT MED-LAUSANNE 润色咨询

Frontiers in Medicine

出版年份:暂无数据 年文章数:5853 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2020-12-08 Tina1130

    我投了3个月了,中间换了3次编辑,什么情况啊

    9

    展开9条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-09-27 124fad42m35暂无昵称

    请问一下这个杂志要找几个审稿人啊

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2022-12-22 William chen 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:针灸;内科;穴位按压
    经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。
    总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。
    2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。
    9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。
    11月5日另一个reviewer也同意了。
    然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。
    祝大家好运!

    7

    展开7条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2020-11-05 123bf506m78暂无昵称

    这个杂志大概多久分配编辑。然后多久送外审?

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2022-03-11 ms3000000556942775

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:流行病学
    经验分享:文章接受了,但是上预警期刊了

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-11-17 一只虫虫

    做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……

    6

    展开6条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2022-06-26 145f7fc8m73暂无昵称

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2022-01-14 1461a9cfm23暂无昵称

    Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-03-12 ms8000001139656647

    投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=905857, encodeId=f5a590585ee6, content=我投了3个月了,中间换了3次编辑,什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Tue Dec 08 01:19:55 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=897164, encodeId=aea789e1642b, content=这个杂志大概多久分配编辑。然后多久送外审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=123bf506m78暂无昵称, createdTime=Thu Nov 05 17:05:33 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:流行病学<br>经验分享:文章接受了,但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的,投稿一周让转投到frontiers in Oncology ,感觉要被拒,但还是同意了,因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息,催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947580, encodeId=e72c94e580d2, content=投稿一个多月 小修 5天返修 然后审稿人2很快同意发表 但审稿人1一直没有消息 怎么办啊有谁知道怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e315412835, createdName=ms8000001139656647, createdTime=Fri Mar 12 07:54:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003603, encodeId=083d1003603db, content=恕我直言,慢的要死!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Thu Jul 29 15:32:27 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-07-29 ms8000000158580549

    恕我直言,慢的要死!

    5

    展开5条回复
共230条页码: 1/23页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分